Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

151 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   Abelmoschus manihot   -   -   -   -   [1]
66 
 2   Ace inhibitor   -   -   -   -   [1]
66 
 3   Ace inhibitor or angiotensin receptor antagonist   Angiotensin ii   D00150, D02014   [2] AGTR1, AGTR2   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
66 
 4   Ace/arb   -   -   -   -   [1]
66 
 5   Acei   -   -   -   -   [2]
66,
224 
 6   Acei/arb and corticosteroids   -   -   -   -   [1]
66 
 7   Acteoside   Acteoside   -   -   -   [1]
66 
 8   Acth   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [5]
13,
66,
145,
193,
222 
 9   Acth (acthar) gel   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
66 
 10   Acthar 80 unit injection   -   -   -   -   [1]
66 
 11   Aliskiren   Aliskiren   D03208   [1] REN   [2] Renin secretion, Renin-angiotensin system   [3]
66,
167,
222 
 12   Allopurinol   Allopurinol   D00224   [1] XDH   [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism   [6]
6,
46,
57,
66,
96,
97 
 13   Angiotensin   Angiotensin ii   D00150, D02014   [2] AGTR1, AGTR2   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [7]
17,
19,
46,
66,
86,
222,
224 
 14   Angiotensin blockade   Angiotensin ii   D00150, D02014   [2] AGTR1, AGTR2   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
66 
 15   Angiotensin ii   Angiotensin ii   D00150, D02014   [2] AGTR1, AGTR2   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
66,
222 
 16   Apl-2   -   -   -   -   [5]
61,
62,
66,
222,
223 
 17   Atacicept   Atacicept   D09704   [2] TNFSF13, TNFSF13B   [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   [4]
13,
46,
49,
66 
 18   Atacicept 150 mg   Atacicept   D09704   [2] TNFSF13, TNFSF13B   [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   [3]
13,
49,
66 
 19   Atacicept 25 mg   Atacicept   D09704   [2] TNFSF13, TNFSF13B   [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   [2]
13,
66 
 20   Atacicept 75 mg   Atacicept   D09704   [2] TNFSF13, TNFSF13B   [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis   [3]
13,
49,
66 
 21   Atacicept150mg   -   -   -   -   [1]
66 
 22   Atacicept25mg   -   -   -   -   [1]
66 
 23   Atacicept75mg   -   -   -   -   [1]
66 
 24   Atg-f   -   -   -   -   [1]
66 
 25   Azathioprine   Azathioprine   D00238, D03033   -   -   [18]
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 26   Bardoxolone   Bardoxolone   D09584   -   -   [7]
66,
67,
84,
85,
86,
218,
222 
 27   Bardoxolone methyl   Bardoxolone methyl   D09585   -   -   [7]
66,
67,
84,
85,
86,
218,
222 
 28   Bardoxolone methyl capsules   Bardoxolone methyl   D09585   -   -   [4]
66,
67,
86,
222 
 29   Betaloc   Metoprolol   D00601, D02358, D05011   [1] ADRB1   [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy (DCM), Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   [1]
66 
 30   Bion-1301 multiple doses   -   -   -   -   [1]
66 
 31   Bion-1301 single dose   -   -   -   -   [1]
66 
 32   Blisibimod   Blisibimod   D10311   -   -   [5]
43,
44,
49,
63,
66 
 33   Blood sample   -   -   -   -   [12]
8,
13,
46,
49,
51,
53,
61,
66,
97,
274,
288,
299 
 34   Bortezomib   Bortezomib   D03150   [1] PSMB5   [1] Proteasome   [13]
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 35   Bortezomib (velcade®)   Bortezomib   D03150   [1] PSMB5   [1] Proteasome   [1]
66 
 36   Budesonide   Budesonide   D00246   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [9]
66,
93,
94,
95,
96,
97,
98,
228,
299 
 37   Calcitriol   Calcitriol   D00129   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [8]
37,
46,
49,
66,
96,
158,
235,
326 
 38   Ccx168   -   -   -   -   [6]
43,
44,
66,
109,
222,
223 
 39   Cemdisiran   -   -   -   -   [2]
66,
109 
 40   Chinese herb prescription granule plus prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 41   Cilazapril   Cilazapril   D01069, D07699   [1] ACE   [4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   [1]
66 
 42   Corticosteroid   -   -   -   -   [10]
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 43   Corticotherapy   -   -   -   -   [1]
66 
 44   Cyclophosphamid   Cyclophosphamide   D00287, D07760   -   -   [1]
66 
 45   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 46   Dipyridamole   Dipyridamole   D00302   [2] PDE4A, PDE5A   [6] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway   [5]
46,
49,
51,
66,
224 
 47   Enalapril   Enalapril   D00621, D07892   [1] ACE   [4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   [4]
19,
46,
66,
113 
 48   Enalapril valsartan methylprednisone   Methylprednisone   -   -   -   [1]
66 
 49   Fecal microbiota transplantation   -   -   -   -   [5]
2,
66,
94,
96,
97 
 50   Fish oil   Fish oil   -   -   -   [7]
13,
46,
49,
66,
96,
260,
299 
 51   Fostamatinib   Fostamatinib   D09347   [1] SYK   [15] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   [4]
46,
49,
61,
66 
 52   Fostamatinib 100 mg   Fostamatinib   D09347   [1] SYK   [15] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   [1]
66 
 53   Fostamatinib 150 mg   Fostamatinib   D09347   [1] SYK   [15] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   [1]
66 
 54   Fostamatinib disodium tablet 100 mg   Fostamatinib   D09347   [1] SYK   [15] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   [1]
66 
 55   Fostamatinib disodium tablet 150 mg   Fostamatinib   D09347   [1] SYK   [15] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis   [1]
66 
 56   Gastrus   -   -   -   -   [1]
66 
 57   Hormone (prednisone)   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 58   Human soluble recombinant fc-gamma receptor iib   -   -   -   -   [1]
66 
 59   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   [18]
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 60   Hydroxychloroquine sulfate   Hydroxychloroquine   D08050   -   -   [2]
46,
66 
 61   Immunosuppressive agents   -   -   -   -   [2]
50,
66 
 62   Immunosuppressive treatment   -   -   -   -   [1]
66 
 63   Inhibace/cozaar   -   -   -   -   [1]
66 
 64   Intravenous rituximab   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [1]
66 
 65   Ionis-fb-lrx   -   -   -   -   [1]
66 
 66   Irbesartan   Irbesartan   D00523   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [4]
66,
167,
168,
222 
 67   Irbesartan tablets   Irbesartan   D00523   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
66,
222 
 68   Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03   Irbesartan   D00523   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
66,
222 
 69   Leflunomide   Leflunomide   D00749   [1] DHODH   [2] Metabolic pathways, Pyrimidine metabolism   [9]
11,
40,
46,
49,
53,
66,
224,
271,
300 
 70   Leflunomide 20 mg+prednisone 0.5mg/kg/d   Leflunomide   D00749   [1] DHODH   [2] Metabolic pathways, Pyrimidine metabolism   [1]
66 
 71   Lisinopril   Lisinopril   D00362, D08131   [1] ACE   [4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   [5]
46,
66,
67,
113,
222 
 72   Lnp023   -   -   -   -   [3]
62,
66,
222 
 73   Losartan   Losartan   D00357, D08146   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [18]
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 74   Low antigen content diet   -   -   -   -   [1]
66 
 75   Menatetrenone   Menatetrenone   D00100   -   -   [1]
66 
 76   Methylprednisolon   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [4]
13,
51,
66,
222 
 77   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [36]
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 78   Methylprednisolone (mp) or prednisone (pred)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 79   Methylprednisolone mylan générique   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 80   Methylprednisolone pulse   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [2]
66,
220 
 81   Methylprednisolone(intravenously in the 1st-2nd-3rd month )   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 82   Methylprednisolone(intravenously in the 1st-3rd-5th month)   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 83   Methylprednisone   Methylprednisone   -   -   -   [3]
46,
66,
222 
 84   Mizoribine   Mizoribine   D01392   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [7]
49,
51,
53,
66,
94,
222,
224 
 85   Multi-glycoside of tripterygium wilfordii hook. f. (twh)   Tripterygium wilfordii whole   -   -   -   [1]
66 
 86   Mycophenolate   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [33]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 87   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [32]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 88   Mycophenolate mofetil (mmf)   Mycophenolate mofetil   D00752, D05094, D05095   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [4]
49,
60,
66,
222 
 89   Mycophenolate mofetil plus lower dose of prednisone   Mycophenolate mofetil   D00752, D05094, D05095   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [1]
66 
 90   Mycophenolate sodium   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [3]
53,
66,
222 
 91   Mycophenolic acid   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [7]
11,
49,
51,
60,
66,
96,
222 
 92   Mycophenolic sodium   -   -   -   -   [2]
66,
222 
 93   Myfortic   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [4]
49,
66,
222,
228 
 94   Myfortic 180mg tablets   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [2]
66,
222 
 95   Myfortic 360mg tablets   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [2]
66,
222 
 96   Nefecon   -   -   -   -   [1]
66 
 97   Omega-3   Omega-3 fatty acids   -   -   -   [7]
13,
46,
49,
66,
79,
96,
299 
 98   Omega-3 fatty acid   Omega-3 fatty acids   -   -   -   [2]
46,
66 
 99   Omega-3 fatty acid ethylester90   Omega-3 fatty acids   -   -   -   [1]
66 
 100   Omega-3 fatty acid fish oil supplement   Fish oil   -   -   -   [1]
66 
 101   Oms721   -   -   -   -   [5]
64,
66,
109,
222,
223 
 102   Opl-ccl2-lpm   -   -   -   -   [1]
66 
 103   Over-encapsulated 150 mg irbesartan tablets   Irbesartan   D00523   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
66 
 104   Over-encapsulated irbesartan tablets   Irbesartan   D00523   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
66,
222 
 105   Paricalcitol   Paricalcitol   D00930   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [3]
19,
66,
218 
 106   Placebo   -   -   -   -   [20]
3,
6,
13,
14,
40,
46,
49,
50,
51,
66,
67,
79,
85,
86,
88,
96,
97,
144,
149,
226 
 107   Potassium   Potassium   D08403   -   -   [9]
46,
66,
67,
98,
115,
167,
179,
215,
235 
 108   Prednisolon   -   -   -   -   [4]
46,
66,
96,
97 
 109   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [38]
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 110   Prednisone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [43]
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 111   Prednisone + inhibace/cozaar   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 112   Prednisone 5 mg   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [2]
46,
66 
 113   Prednisone alone   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [2]
11,
66 
 114   Prednisone and cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [1]
66 
 115   Prednisone arrow 20mg   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 116   Prednisone arrow 5 mg   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 117   Prednisone in full dose   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 118   Prednisone or prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
66 
 119   Prednisone plus cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [1]
66 
 120   Probucol   Probucol   D00476   -   -   [1]
66 
 121   Protectis   -   -   -   -   [1]
66 
 122   Ramipril   Ramipril   D00421   [1] ACE   [4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system   [7]
46,
49,
66,
67,
113,
218,
257 
 123   Rapamune   Sirolimus   D00753   [1] MTOR   [43] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   [5]
2,
60,
66,
67,
158 
 124   Re-021   -   -   -   -   [2]
66,
222 
 125   Reh-acteoside   Acteoside   -   -   -   [1]
66 
 126   Renin angiotensin system (ras) blockade   Angiotensin ii   D00150, D02014   [2] AGTR1, AGTR2   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [1]
66 
 127   Risedronate   Risedronic acid   D00942, D03234, D08484   [1] FDPS   [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis   [5]
46,
66,
96,
113,
274 
 128   Rituximab   Rituximab   D02994   [1] MS4A1   [1] Hematopoietic cell lineage   [42]
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 129   Simulect   Basiliximab   D03058   [1] IL2RA   [11] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor   [2]
66,
97 
 130   Simvastatin   Simvastatin   D00434   [1] HMGCR   [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis   [19]
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310 
 131   Sirolimus   Sirolimus   D00753   [1] MTOR   [43] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   [30]
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 132   Sm101   -   -   -   -   [3]
49,
63,
66 
 133   Sparsentan   Sparsentan   -   -   -   [2]
66,
222 
 134   Steroids   -   -   -   -   [7]
46,
50,
51,
63,
66,
96,
97 
 135   Steroids plus azathioprine   Azathioprine   D00238, D03033   -   -   [1]
66 
 136   Sulfate   Sulfate ion   -   -   -   [22]
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 137   Supportive and immunosuppressive therapy   -   -   -   -   [1]
66 
 138   Supportive therapy   -   -   -   -   [1]
66 
 139   Supportive therapy with: ace-inhibitor / arb / statin   -   -   -   -   [1]
66 
 140   Tacrolimus   Tacrolimus   D00107, D08556   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [29]
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 141   Tailored diet   -   -   -   -   [1]
66 
 142   Telmisartan   Telmisartan   D00627   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [2]
66,
67 
 143   The yi-qi-qing-jie herbal compound   -   -   -   -   [1]
66 
 144   Tripterygium   Tripterygium wilfordii whole   -   -   -   [8]
46,
66,
67,
96,
162,
222,
224,
271 
 145   Tripterygium wilfordii   Tripterygium wilfordii whole   -   -   -   [6]
46,
66,
67,
222,
224,
271 
 146   Tripterygium wilfordii (tw)   Tripterygium wilfordii whole   -   -   -   [2]
66,
222 
 147   Valsartan   Valsartan   D00400   [1] AGTR1   [14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   [6]
57,
58,
66,
75,
218,
222 
 148   Vis649   -   -   -   -   [1]
66 
 149   Warfarin   Warfarin   D00564, D01280, D08682   [2] NQO1, VKORC1   [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis   [10]
6,
8,
13,
19,
46,
49,
66,
85,
88,
96 
 150   Wm (shentong granules)   -   -   -   -   [1]
66 
 151    lnp023 hydrochloride salt   -   -   -   -   [2]
62,
66 

Back to top